Opinion statement
This review focuses on recent advances in the treatment of traumatic brain injury (TBI) during 2004 and 2005. Injured brain is a very heterogeneous structure, significantly evolving over time. Implementation of multimodal neuromonitoring will certainly provide more insights into pathophysiology of TBI. More studies are needed to determine how to best incorporate these new parameters into effective management protocols. Based on current literature, corticosteroids should not be indicated for the treatment of TBI. Avoidance or immediate treatment of secondary insults remains a mainstream of clinical care for patients with TBI. It seems that the therapy should focus on control of intracranial hypertension, and values of cerebral perfusion pressure around 60 mm Hg appear to correlate with favorable outcome in most patients. Hypertonic saline may become a preferred osmotherapeutic agent in severely head-injured patients, especially those with refractory intracranial hypertension. Benefit and indications for performing a decompressive craniectomy remain to be determined. Overall, individualized treatment respecting actual status of a patient’s intra- and extracranial homeostasis should be the key principle of our current therapeutic approach toward severely head-injured patients.
Similar content being viewed by others
References and Recommended Reading
National Center for Injury Prevention and Control: Injury FactBook 2001–2002. Centers for Disease Control and Prevention: Atlanta, GA; 2001:1–125.
Narayan R, Michel ME, Ansell B, et al.: Clinical trials in head injury. J Neurotrauma 2002, 19:503–557. This important article extensively summarizes the recent status of clinical trials in TBIs.
Sosin DM, Sniezek JE, Thurman DJ: Incidence of mild and moderate brain injury in the United States, 1991. Brain Inj 1996, 10:47–54.
Hohenstein A, Erber R, Schilling L, Weigel R: Increased mRNA expression of VEGF within the hematoma and imbalance of angiopoietin-1 and -2 mRNA within the neomembranes of chronic subdural hematoma. J Neurotrauma 2005, 22:518–528.
Hillered L, Vespa PM, Hovda DA: Translational neurochemical research in acute human brain injury: the current status and potential future for cerebral microdialysis. J Neurotrauma 2005, 22:3–41. This important article extensively summarizes the current knowledge of intracerebral microdialysis.
Ashwal S, Holshouser B, Tong K, et al.: Proton MR spectroscopy detected glutamate/glutamine is increased in children with traumatic brain injury. J Neurotrauma 2004, 21:1539–1552.
Fountas KN, Sitkauskas A, Feltes CH, et al.: Is noninvasive monitoring of intracranial pressure waveform analysis possible? Preliminary results of a comparative study of non-invasive vs. invasive intracranial slow-wave waveform analysis monitoring in patients with traumatic brain injury. Med Sci Monit 2005, 11:CR58-CR63.
Voulgaris SG, Partheni M, Kaliora H, et al.: Early cerebral monitoring using the transcranial Doppler pulsatility index in patients with severe brain trauma. Med Sci Monit 2005, 11:CR49-CR52.
Deogaonkar A, Gupta R, DeGeorgia M, et al.: Bispectral Index monitoring correlates with sedation scales in braininjured patients.Crit Care Med 2004, 32:2403–2406.
Vespa P, Bergsneider M, Hattori N, et al.: Metabolic crisis without brain ischemia is common after traumatic brain injury: a combined microdialysis and positron emission tomography study. J Cereb Blood Flow Metab 2005, 25:763–774.
Parkin M, Hopwood S, Jones DA, et al.: Dynamic changes in brain glucose and lactate in pericontusional areas of the human cerebral cortex, monitored with rapid sampling on-line microdialysis: relationship with depolarisation-like events. J Cereb Blood Flow Metab 2005, 25:402–413.
CRASH Trial Management Group: Research in emergency situations: with or without relatives consent. Emerg Med J 2004, 21:703. Study discusses an issue of surrogate consent versus waiving of informed consent.
Roberts I, Yates D, Sandercock P, et al.: Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomized placebo-controlled trial. Lancet 2004, 364:1321–1328.
Edwards P, Arango M, Balica L, et al.: Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury outcomes at 6 months.Lancet 2005, 365:1957–1959. Study presents result of MRC, comparing methylprednisolone versus placebo in patients with TBIs.
Kemp S, Biswas R, Neumann V, Coughlan A: The value of melatonin for sleep disorders occurring post-head injury: a pilot RCT.Brain Inj 2004, 18:911–919.
Tenovuo O: Central acetylcholinesterase inhibitors in the treatment of chronic traumatic brain injury-clinical experience in 111 patients.Prog Neuropsychopharmacol Biol Psychiatry 2005, 29:61–67.
McKee JA, Brewer RP, Macy GE, et al.: Analysis of the brain bioavailability of peripherally administered magnesium sulfate: a study in humans with acute brain injury undergoing prolonged induced hypermagnesemia. Crit Care Med 2005, 33:661–666.
Bourgoin A, Albanese J, Leone M, et al.: Effects of sufentanil or ketamine administered in target-controlled infusion on the cerebral hemodynamics of severely brain-injured patients. Crit Care Med 2005, 33:1109–1113.
Karabinis A, Mandragos K, Stergiopoulos S, et al.: Safety and efficacy of analgesia-based sedation with remifentanil versus standard hypnotic-based regimens in intensive care unit patients with brain injuries: a randomised, controlled trial [ISRCTN50308308]. Crit Care 2004, 8:R268-R280.
Martinez-Perez M, Bernabe F, Pena R, et al.: Effects of expiratory tracheal gas insufflation in patients with severe head trauma and acute lung injury. Intensive Care Med 2004, 30:2021–2027.
Kurtoglu M, Yanar H, Bilsel Y, et al.: Venous thromboembolism prophylaxis after head and spinal trauma: intermittent pneumatic compression devices versus low molecular weight heparin. World J Surg 2004, 28:807–811.
Bouderka MA, Fakhir B, Bouaggad A, et al.: Early tracheostomy versus prolonged endotracheal intubation in severe head injury. J Trauma 2004, 57:251–254.
Mayer SA, Kowalski RG, Presciutti M, et al.: Clinical trial of a novel surface cooling system for fever control in neurocritical care patients. Crit Care Med 2004, 32:2508–2515.
Battison C, Andrews PJ, Graham C, Petty T: Randomized, controlled trial on the effect of a 20% mannitol solution and a 7.5% saline/6% dextran solution on increased intracranial pressure after brain injury. Crit Care Med 2005, 33:196–202; discussion 257–258.
Ware ML, Nemani VM, Meeker M, et al.: Effects of 23.4% sodium chloride solution in reducing intracranial pressure in patients with traumatic brain injury: a preliminary study. Neurosurgery 2005, 57:727–736.
Bullock RM, Chesnut R, Clifton GL, et al.: Management and prognosis of severe traumatic brain injury. Part 1: guidelines for management of severe traumatic brain injury. J Neurotrauma 2000, 17:449–597. Essential literature presenting evidence-based information about treatment of severely head-injured patients.
Howells T, Elf K, Jones PA, et al.: Pressure reactivity as a guide in the treatment of cerebral perfusion pressure in patients with brain trauma. J Neurosurg 2005, 102:311–317.
Elf K, Nilsson P, Ronne-Engstrom E, et al.: Cerebral perfusion pressure between 50 and 60 mm Hg may be beneficial in head-injured patients: a computerized secondary insult monitoring study. Neurosurgery 2005, 56:962–971.
Jiang JY, Xu W, Li WP, et al.: Efficacy of standard trauma craniectomy for refractory intracranial hypertension with severe traumatic brain injury: a multicenter, prospective, randomized controlled study. J Neurotrauma 2005, 22:623–628.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bell, S.E., Hlatky, R. Update in the treatment of traumatic brain injury. Curr Treat Options Neurol 8, 167–175 (2006). https://doi.org/10.1007/s11940-006-0007-9
Issue Date:
DOI: https://doi.org/10.1007/s11940-006-0007-9